Trade

with

CK Life Sciences International Holdings Inc
(Germany: LSI)
AdChoices
0.0800
+0.0010
+1.27%
After Hours :
-
-
-

Open

0.0800

Previous Close

0.0790

Volume (Avg)

0 (-)

Day's Range

0.0800-0.0800

52Wk Range

-

Market Cap.

759.27M

Dividend Rate (Yield )

0.00 (0.84%)

Beta

0.41

Shares Outstanding

9.61B

P/E Ratio (EPS)

31.55 (0.00)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 505.64M

    • Net Income

    • 23.86M

    • Market Cap.

    • 759.27M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 4.80

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.41

    • Forward P/E

    • -

    • Price/Sales

    • 1.52

    • Price/Book Value

    • 1.35

    • Price/Cash flow

    • 24.81

      • EBITDA

      • 55.35M

      • Return on Capital %

      • 2.30

      • Return on Equity %

      • 4.40

      • Return on Assets %

      • 2.30

      • Book Value/Share

      • 0.01

      • Shares Outstanding

      • 9.61B

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.00 (5/20/2014)

      • Dividend Declaration Date

      • 2/24/2014

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

          • Sales (Revenue)

            Q/Q (last year)

          • -

          • Net Income

            YTD/YTD (last year)

          • 18.40

          • Net Income

            Q/Q (last year)

          • -

          • Sales (Revenue)

            5-Year Annual Average

          • 10.69

          • Net Income

            5-Year Annual Average

          • -

          • Dividends

            5-Year Annual Average

          • -

          • Profit Margins (%)

          • Company

            • Gross Margin

            • 34.79

            • Pre-Tax Margin

            • 6.01

            • Net Profit Margin

            • 4.80

            • Average Gross Margin

              5-Year Annual Average

            • 32.90

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 6.70

            • Average Net Profit Margin

              5-Year Annual Average

            • 5.40

            • Financial Ratios

            • Company

              • Debt/Equity Ratio

              • 0.55

              • Current Ratio

              • 1.35

              • Quick Ratio

              • 0.84

              • Interest Coverage

              • 3.70

              • Leverage Ratio

              • 1.93

              • Book Value/Share

              • 0.06

              • Price Ratios

              • Company

                • Current P/E Ratio

                • 31.55

                • P/E Ratio 5-Year High

                • 34.79

                • P/E Ratio 5-Year Low

                • 10.00

                • Price/Sales Ratio

                • 1.52

                • Price/Book Value

                • 1.35

                • Price/Cash Flow Ratio

                • 24.81

                • Key Metrics

                • Company

                  • Return on Equity %

                    (5-Year Average)

                  • 4.40

                    (3.50)

                  • Return on Assets %

                    (5-Year Average)

                  • 2.30

                    (2.30)

                  • Return on Capital %

                    (5-Year Average)

                  • 3.56

                    (2.20)

                  • Income/Employee

                  • 147.82k

                  • Inventory Turnover

                  • 3.30

                  • Asset Turnover

                  • 0.48

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  36.99M
                  Operating Margin
                  7.32
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  24.81
                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  -

                  Style

                  Mid Core

                  CK Life Sciences International Holdings, Inc., is an investment holding company. The Company and its subsidiaries are engaged in research & development, manufacturing, commercialization, marketing and selling of health and agriculture related products.

                  Key People

                  Dean Corbett

                  Chief Executive Officer - Accensi Pty Ltd

                  Bob Opacic

                  Chief Executive Officer - Amgrow Pty Ltd.

                  Nick Gill

                  Chief Executive Officer - Belvino Investments Pty Ltd

                  Dusko Pejnovic

                  Chief Executive Officer - Lipa Pharmaceuticals Ltd.

                  John Chiplin PhD,BPharm,MRPharmS

                  Chief Executive Officer - Polynoma LLC

                  • CK Life Sciences International Holdings Inc

                  • 2 Dai Fu Street

                  • Hong Kong,

                  • CYM.Map

                  • Phone: +852 21261212

                  • Fax: +852 21261211

                  • ck-lifesciences.com

                  Incorporated

                  0

                  Employees

                  1,635